Product NDC: | 0781-3132 |
Proprietary Name: | Methylprednisolone Acetate |
Non Proprietary Name: | Methylprednisolone Acetate |
Active Ingredient(s): | 80 mg/mL & nbsp; Methylprednisolone Acetate |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PARENTERAL; SOFT TISSUE |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3132 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040794 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090305 |
Package NDC: | 0781-3132-71 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3132-71) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0781-3132-71 |
Proprietary Name | Methylprednisolone Acetate |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3132-71) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0781-3132 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone Acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PARENTERAL; SOFT TISSUE |
Start Marketing Date | 20090305 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | METHYLPREDNISOLONE ACETATE |
Strength Number | 80 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |